JP2024505967A5 - - Google Patents
Info
- Publication number
- JP2024505967A5 JP2024505967A5 JP2023546457A JP2023546457A JP2024505967A5 JP 2024505967 A5 JP2024505967 A5 JP 2024505967A5 JP 2023546457 A JP2023546457 A JP 2023546457A JP 2023546457 A JP2023546457 A JP 2023546457A JP 2024505967 A5 JP2024505967 A5 JP 2024505967A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- pharmaceutical composition
- eating
- active ingredient
- triazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2021052373 | 2021-02-02 | ||
| EPPCT/EP2021/052373 | 2021-02-02 | ||
| PCT/EP2022/051992 WO2022167330A1 (en) | 2021-02-02 | 2022-01-28 | A crystalline form of (4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(r)-3-(3-[1,2,3]triazol-2-yl-benzyl)-morpholin-4-yl]-methanone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024505967A JP2024505967A (ja) | 2024-02-08 |
| JP2024505967A5 true JP2024505967A5 (cg-RX-API-DMAC10.html) | 2025-02-04 |
Family
ID=80445564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546457A Pending JP2024505967A (ja) | 2021-02-02 | 2022-01-28 | （４－メチル－２－［１，２，３］トリアゾール－２－イル－フェニル）－［（ｒ）－３－（３－［１，２，３］トリアゾール－２－イル－ベンジル）－モルホリン－４－イル］－メタノンの結晶形 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240116913A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4288432A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024505967A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230142742A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116724037A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3206675A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202241447A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022167330A1 (cg-RX-API-DMAC10.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2776430T1 (sl) | 2011-11-08 | 2016-06-30 | Actelion Pharmaceuticals Ltd. | 2-(1,2,3-triazol-2-il)benzamidni in 3-(1,2,3-triazol-2-il)pikolinamidni derivati kot antagonisti oreksinskega receptorja |
| US10117836B2 (en) * | 2014-02-05 | 2018-11-06 | Merck Sharp & Dohme Corp. | Tablet formulation for CGRP active compounds |
| DK3556354T3 (da) * | 2016-12-15 | 2025-08-04 | Hua Medicine Shanghai Ltd | Oral fremstilling af en glucokinaseaktivator og fremgangsmåde til fremstilling deraf |
| AR114353A1 (es) * | 2018-02-02 | 2020-08-26 | Novo Nordisk As | Composiciones sólidas que comprenden un agonista del glp-1 y una sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico |
-
2022
- 2022-01-28 WO PCT/EP2022/051992 patent/WO2022167330A1/en not_active Ceased
- 2022-01-28 US US18/263,847 patent/US20240116913A1/en active Pending
- 2022-01-28 EP EP22703330.5A patent/EP4288432A1/en active Pending
- 2022-01-28 CN CN202280011857.6A patent/CN116724037A/zh active Pending
- 2022-01-28 TW TW111104122A patent/TW202241447A/zh unknown
- 2022-01-28 KR KR1020237029001A patent/KR20230142742A/ko active Pending
- 2022-01-28 JP JP2023546457A patent/JP2024505967A/ja active Pending
- 2022-01-28 CA CA3206675A patent/CA3206675A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2688695A1 (en) | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione | |
| US7629374B2 (en) | Use of aminoindazole derivatives for the inhibition of tau phosphorylation | |
| WO2003037881A1 (en) | α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE | |
| JP2010132680A (ja) | Ｐｇｄ２受容体拮抗作用を有する化合物 | |
| IL98392A (en) | Indole derivatives their preparation and pharmaceutical compositions containing them | |
| JP2008266337A (ja) | セロトニン１ａ受容体に対して活性を有するアリールピペラジン | |
| JP2001526643A (ja) | ５ｈｔ１ａ、５ｈｔ１ｂおよび５ｈｔ１ｄ受容体アンタゴニスト活性を合わせ持つ化合物を含む二環式アリールまたは二環式複素環 | |
| JP2014074067A (ja) | メシル酸イマチニブのｆ、ｇ、ｈ、ｉおよびｋ結晶形 | |
| TW201617349A (zh) | ２－氧雜－５－氮雜雙環［２．２．１］庚－３－基衍生物 | |
| JP2024530045A (ja) | リナプラザングルレート塩酸塩の多形 | |
| JP2010235635A (ja) | 多酸性塩基化合物の酸付加塩の製造方法 | |
| TW200526573A (en) | Organic compounds | |
| JP2025512920A5 (cg-RX-API-DMAC10.html) | ||
| JP2010120949A (ja) | 治療化合物 | |
| JP2020073513A (ja) | α，ω‐二置換ジヒドロキシシクロペンチル化合物の固体形態、並びにその製造及び使用方法 | |
| JP2012512145A (ja) | フリバンセリンの結晶性の塩形態 | |
| JP2023517729A5 (cg-RX-API-DMAC10.html) | ||
| JP2004504390A (ja) | （ｒ）−ｎ−［５−メチル−８−（４−メチルピペラジン−１−イル）−１，２，３，４−テトラヒドロ−２−ナフチル］−４−モルホリノベンズアミドの新規な形態 | |
| JP2007536358A (ja) | 抗糖尿病性ロシグリタゾン誘導体の合成 | |
| HUP0001878A2 (hu) | (R)-3-(N,N-diciklobutil-amino)-8-fluor-3,4-dihidro-2H-1-benzopirán-5-karboxamid-hidrogén tartarát, eljárás előállítására és ezt tartalmazó gyógyszerkészítmények | |
| CN1379776A (zh) | 包含噻唑烷二酮衍生物的药物组合物及其制备方法 | |
| JP2008195654A (ja) | ベンゾ［ｂ］フラン化合物の新規結晶形 | |
| JP2011102241A (ja) | 新規１−アミノカルボニルピペリジン誘導体 | |
| KR101220328B1 (ko) | 벤조사이오펜 화합물 | |
| TW421647B (en) | (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides |